# Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

> **NCT05088798** · PHASE2 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 100 (estimated)

## Conditions studied

- Hyperinsulinism

## Interventions

- **DRUG:** 18F-Fluoro Dopa PET/MRI Imaging

## Key facts

- **NCT ID:** NCT05088798
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-10
- **Primary completion:** 2030-01-01
- **Final completion:** 2030-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05088798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05088798, "Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05088798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*